Technology: biomarkers
Industry: Biotechnology, Health Care, Science and Engineering
Headquarters: United States
Founded Date: 2013-01-01
Employees Number: 101-250
Funding Status: Late Stage Venture
Investor Type: Company
Investment Stage: N/A
Number Of Exits: Series C
Acquisitions Number: 2
Investors Number: 13
Total Funding: 330000000 USD
Estimated Revenue: $10M to $50M
Last Funding Date: 2019-11-07
Last Funding Type: Series C

Visit Website
clientservices@humanlongevity.com
http://twitter.com/humanlongevity
Register and Claim Ownership